Epiglottitis

Comprehensive Clinical Guide: Epiglottitis

Epiglottitis (also known as supraglottitis) is a rapidly progressive, potentially life-threatening inflammation of the epiglottis and adjacent supraglottic structures. It represents a true medical emergency, characterized by the potential for sudden, total airway obstruction. Historically associated with pediatric populations, the clinical landscape has shifted significantly following the widespread implementation of the Haemophilus influenzae type b (Hib) vaccine. In the modern era, epiglottitis is increasingly recognized in adult populations, necessitating a high index of clinical suspicion across all age groups.

1. Etiology and Pathophysiology

Microbial Etiology

While the incidence of Haemophilus influenzae type b has plummeted in vaccinated populations, it remains a primary pathogen in unvaccinated individuals or those with waning immunity. Current epidemiological data suggests a shift toward a broader spectrum of pathogens.

Pathophysiological Mechanism

The pathogenesis begins with the inoculation of the oropharyngeal mucosa. Once the epithelial barrier is compromised, the pathogen invades the loose areolar tissue of the lingual surface of the epiglottis.

1. Inflammatory Cascade: Rapid infiltration of neutrophils and inflammatory mediators leads to significant edema.
2. Anatomical Vulnerability: The epiglottis is anchored to the hyoid bone, and the supraglottic space is highly distensible. Edema here results in a "cherry-red" appearance and profound swelling.
3. Airway Compromise: As the epiglottis swells, it curls posteriorly, obstructing the laryngeal inlet. The "ball-valve" effect occurs during inspiration, where the edematous tissue is sucked into the glottis, leading to acute respiratory failure.

2. Clinical Presentation and Staging

Standard Presentation

The classic presentation—the "4 Ds"—is more reliable in children than adults, who often present with a more insidious onset.

• Drooling: Inability to manage oral secretions due to painful dysphagia.
• Dysphagia: Significant pain and difficulty swallowing.
• Dysphonia: A "hot potato" or muffled voice quality.
• Distress: Respiratory effort, stridor, and use of accessory muscles.

Clinical Staging/Grading (Modified Stott Classification)

Clinical severity is often graded to determine the aggressiveness of the airway management strategy.

Note: Any patient exhibiting signs of Grade II or III requires immediate transfer to an operating room for controlled airway management.

3. Diagnostic Modalities

The "Do Not" List

• Do NOT attempt visualization of the pharynx with a tongue depressor in a patient with suspected epiglottitis. This can trigger a laryngospasm and complete airway obstruction.
• Do NOT perform unnecessary imaging that delays airway management.

Key Diagnostic Tests

1. Fiberoptic Nasolaryngoscopy: The gold standard for diagnosis. Performed by an ENT specialist or anesthesiologist in a controlled environment. Allows for direct visualization of the edematous, cherry-red epiglottis.
2. Lateral Soft Tissue Neck X-Ray: Though less sensitive than endoscopy, it is a useful adjunct.
   • The "Thumb Sign": Indicates a swollen epiglottis.
   • Vallecula Sign: Loss of the normal air-filled vallecula.
3. Blood Cultures: Positive in approximately 50-70% of cases and essential for pathogen identification.
4. Epiglottal Swab: Often performed after the airway is secured to guide targeted antibiotic therapy.

4. Differential Diagnosis

Distinguishing epiglottitis from other respiratory pathologies is critical.

• Croup (Laryngotracheobronchitis): Usually viral, presents with a "barking" cough, and lacks the severe toxic appearance of epiglottitis.
• Peritonsillar Abscess: Presents with trismus and uvular deviation, usually unilateral.
• Bacterial Tracheitis: Often follows a viral URI; characterized by copious thick, purulent secretions and a "brassy" cough.
• Foreign Body Aspiration: Sudden onset without systemic symptoms (fever/leukocytosis).
• Angioedema: Rapid onset of airway swelling, often associated with ACE inhibitors or allergic triggers; lacks the inflammatory/infectious signs of epiglottitis.

5. Management and Clinical Indications

Immediate Stabilization

1. Positioning: Allow the patient to maintain the "tripod" or "sniffing" position. This optimizes the airway geometry.
2. Oxygenation: Administer humidified oxygen. Do not force masks if it causes agitation.
3. Airway Management:
   • Early ENT/Anesthesia consult is mandatory.
   • The airway should be secured via endotracheal intubation, ideally in the OR under controlled conditions using fiberoptic guidance.
   • Tracheostomy is rarely indicated unless intubation fails or the anatomy is completely distorted.

Pharmacological Therapy

• Empiric Antibiotics: Must cover H. influenzae, Streptococcus, and Staphylococcus.
  • Example: Ceftriaxone (2g IV q24h) + Vancomycin (for MRSA coverage).
• Corticosteroids: While controversial in the literature, dexamethasone is frequently utilized to reduce supraglottic edema.
• Epinephrine: Generally avoided in epiglottitis as it provides only transient relief and may cause rebound edema.

6. Risks, Contraindications, and Long-Term Prognosis

Contraindications

• Forced Supine Positioning: May precipitate total airway collapse.
• Blind Nasotracheal Intubation: Highly contraindicated due to the risk of dislodging the epiglottis and causing total obstruction.

Prognosis

With prompt diagnosis and airway management, the prognosis is excellent. Mortality is almost exclusively linked to acute, unrecognized airway obstruction. Most patients are extubated within 48-72 hours once the inflammatory markers subside and the epiglottis shows signs of resolution on follow-up laryngoscopy.

7. Frequently Asked Questions (FAQ)

1. Is epiglottitis contagious?
Yes, it can be spread through respiratory droplets. Prophylaxis (e.g., Rifampin) may be indicated for close contacts if H. influenzae type b is confirmed.

2. Can adults get epiglottitis?
Yes. In the post-vaccine era, adults represent a significant portion of epiglottitis cases, often presenting with more subtle, prolonged symptoms than children.

3. Why is the "Thumb Sign" significant?
The thumb sign refers to the appearance of the epiglottis on a lateral neck X-ray, resembling a thumb pointing posteriorly, indicating severe swelling.

4. Can I use a tongue depressor to check for epiglottitis?
Absolutely not. It risks triggering a reflex that can cause the epiglottis to collapse over the airway.

5. What is the role of steroids in treatment?
Steroids are used to decrease mucosal edema, though high-quality evidence is limited. They are standard practice in most tertiary care centers.

6. How long does a patient usually stay in the hospital?
Once the airway is secured and the patient is stable on IV antibiotics, the typical length of stay is 3 to 7 days.

7. Is the vaccine effective?
The Hib vaccine is highly effective and has reduced the incidence of pediatric epiglottitis by over 95%.

8. What is the most common cause in adults?
While the etiology varies, Streptococcus species and non-typable H. influenzae are very common in the adult population.

9. Can I diagnose epiglottitis by physical exam alone?
A physical exam of the oropharynx is dangerous. Diagnosis should rely on history, clinical suspicion, and indirect visualization (fiberoptic scope) by a specialist.

10. What is the "tripod position"?
A patient leaning forward, sitting upright, with their hands on their knees or a table, attempting to maximize airway patency. It is a hallmark sign of severe respiratory distress.

Summary of Clinical Best Practices

Epiglottitis requires a calm, systematic, and multidisciplinary approach. By prioritizing airway protection over diagnostic curiosity, clinicians can successfully manage this condition and prevent the devastating sequelae of acute airway failure. Constant vigilance, particularly in patients presenting with sore throat and disproportionate dysphagia, remains the cornerstone of modern management.